Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 100.13
+0.26 (0.26%)
Jul 24, 2026, 3:37 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 982.48 million as of July 24, 2026. Its market cap has increased by 260.27% in one year.
Market Cap
982.48M
Enterprise Value
672.87M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
100.13
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 982.48M, an increase of 1,742.08%. That is a compound annual growth rate of 70.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 982.48M | 14.25% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 536.99M |
| Satellos Bioscience | 290.60M |
| Helix BioPharma | 108.46M |
| ME Therapeutics Holdings | 75.12M |
| Eastwood Bio-Medical Canada | 68.20M |
| MedMira | 45.61M |
| NurExone Biologic | 45.60M |
| BriaCell Therapeutics | 43.76M |